Saturday, May 01, 2010

EHJ editors rebuffed GSK efforts to suppress Nissen editorial on rosiglitazone « CardioBrief

The editors of the European Heart Journal rejected a request by a senior GSK executive to suppress an editorial written by Steve Nissen about rosiglitazone (Avandia).


via cardiobrief.org

Posted via web from Jack's posterous

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)